Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hepatocellular Carcinoma in Hepatitis B Virus-Infected Patients and the Role of Hepatitis B Surface Antigen (HBsAg)
Satinder Kaur, Arslan Talat, Hamidreza Karimi‐Sari, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 4, pp. 1126-1126
Open Access | Times Cited: 25

Showing 25 citing articles:

Chronic Hepatitis B Infection: New Approaches towards Cure
Mojisola Ogunnaike, Srijanee Das, Samiksha S. Raut, et al.
Biomolecules (2023) Vol. 13, Iss. 8, pp. 1208-1208
Open Access | Times Cited: 19
Current Perspectives on the Molecular and Clinical Relationships between Primary Biliary Cholangitis and Hepatocellular Carcinoma
Annarosa Floreani, Daniela Gabbia, Sara De Martin
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2194-2194
Open Access | Times Cited: 6
Inhibition of Autophagy Promotes the Elimination of Liver Cancer Stem Cells by CD133 Aptamer-Targeted Delivery of Doxorubicin
Wang Yin, Cuong Viet Pham, Tao Wang, et al.
Biomolecules (2022) Vol. 12, Iss. 11, pp. 1623-1623
Open Access | Times Cited: 19
Tenofovir versus entecavir on the prognosis of hepatitis B virus-related hepatocellular carcinoma: a systematic review and meta-analysis
Hui Liu, Cheng‐Long Han, Bao‐Wen Tian, et al.
Expert Review of Gastroenterology & Hepatology (2023) Vol. 17, Iss. 6, pp. 623-633
Open Access | Times Cited: 12
Inhibition of Hepatitis B Virus Replication by a Novel GalNAc–siRNA In Vivo and In Vitro
Zhipeng Zhang, Yanqin Ma, Yan He, et al.
ACS Omega (2025) Vol. 10, Iss. 1, pp. 484-497
Open Access
Behaviour‐Based Predictive Scores of Hepatocellular Carcinoma in People With Chronic Hepatitis B (ANRS CO22 HEPATHER)
Clémence Ramier, Camélia Protopopescu, Vincent Di Beo, et al.
Liver International (2025) Vol. 45, Iss. 4
Open Access
Current Advancements in Serum Protein Biomarkers for Hepatitis B Virus‐Associated Hepatocyte Remodeling and Hepatocellular Carcinoma
Adane Adugna, Gashaw Azanaw Amare, Mohammed Jemal
Immunity Inflammation and Disease (2025) Vol. 13, Iss. 4
Open Access
Predictive Risk Factors and Scoring Systems Associated with the Development of Hepatocellular Carcinoma in Chronic Hepatitis B
Ploutarchos Pastras, Evaggelos Zazas, Maria Kalafateli, et al.
Cancers (2024) Vol. 16, Iss. 14, pp. 2521-2521
Open Access | Times Cited: 3
Current and emerging strategies for the prevention of hepatocellular carcinoma
Yee Hui Yeo, Manal F. Abdelmalek, Seema A. Khan, et al.
Nature Reviews Gastroenterology & Hepatology (2024) Vol. 22, Iss. 3, pp. 173-190
Closed Access | Times Cited: 3
Immune Microenvironment and Immunotherapeutic Management in Virus-Associated Digestive System Tumors
Panagiotis Sarantis, Eleni-Myrto Trifylli, Evangelos Koustas, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13612-13612
Open Access | Times Cited: 10
Genetic risk assessment based on association and prediction studies
Nicole Cathlene Astrologo, Joverlyn Gaudillo, Jason R. Albia, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 6
An Ideal Hallmark Closest to Complete Cure of Chronic Hepatitis B Patients: High-sensitivity Quantitative HBsAg Loss
Zilong Wang, Jia-Rui Zheng, Ruifeng Yang, et al.
Journal of Clinical and Translational Hepatology (2022) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 9
Early clinical efficacy of pegylated interferon treatment in patients with different phases of chronic HBV infection: A real‐world analysis
Wencong Zhang, Mingyou Xing, Wenjin Sun, et al.
Journal of Viral Hepatitis (2022) Vol. 30, Iss. 5, pp. 427-436
Open Access | Times Cited: 8
Silymarin Synergizes with Antiviral Therapy in Hepatitis B Virus-Related Liver Cirrhosis: A Propensity Score Matching Multi-Institutional Study
Chien‐Hao Huang, Victor Chien‐Chia Wu, Chunli Wang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3088-3088
Open Access | Times Cited: 1
Immunotherapy Responses in Viral Hepatitis-Induced HCC: A Systematic Review and Meta-Analysis
Junaid Anwar, Hafiz Muhammad Arslan, Zouina Sarfraz, et al.
Current Oncology (2024) Vol. 31, Iss. 11, pp. 7204-7225
Open Access | Times Cited: 1
TACE versus TACE + entecavir versus TACE + tenofovir in the treatment of HBV associated hepatocellular carcinoma
Haohao Lu, Chuansheng Zheng, Bin Xiong, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 3
Secular Trends of Clinical Characteristics and Survival of Hepatocellular Carcinoma in Taiwan from 2011 to 2019
Kwong‐Ming Kee, Chien‐Hung Chen, Jui‐Ting Hu, et al.
Viruses (2022) Vol. 15, Iss. 1, pp. 126-126
Open Access | Times Cited: 5
Liver Carcinogenesis Suppression in Chronic Hepatitis B in the Nucleoside Analogues Era
Hiroki Nishikawa, Soo Ki Kim, Akira Asai
In Vivo (2023) Vol. 38, Iss. 1, pp. 40-47
Open Access | Times Cited: 2
Examining complex cancer etiologies within the Korean population: A high-throughput multivariable Mendelian randomization study
Keum Ji Jung, Wes Spiller, Dae Sub Song, et al.
Research Square (Research Square) (2024)
Open Access
The impact of hepatitis B surface antigen seroconversion on the durability of functional cure induced by pegylated interferon alpha treatment
Wencong Zhang, Jia Chen, Wenjin Sun, et al.
Virology Journal (2024) Vol. 21, Iss. 1
Open Access
Surveillance Following Hepatitis B Surface Antigen Loss: An Issue Requiring Attention
Shuai-Wen Huang, Hong Long, Jiaquan Huang
Pathogens (2024) Vol. 14, Iss. 1, pp. 8-8
Open Access
Clinical Consequences of Hepatitis B Surface Antigen Loss in Chronic Hepatitis B Infection: A Systematic Literature Review and Meta-Analysis
Eleonora Morais, Lauren Mason, John Dever, et al.
Gastro Hep Advances (2023) Vol. 2, Iss. 7, pp. 992-1004
Open Access | Times Cited: 1
Nucleo(s)tide analogue withdrawal in chronic hepatitis B virus infection: Beyond the HBsAg loss
Hamidreza Karimi‐Sari, Mohammad Saeid Rezaee‐Zavareh
Digestive and Liver Disease (2022) Vol. 54, Iss. 9, pp. 1282-1282
Closed Access | Times Cited: 1
Relationship between Hepatitis B Surface Antigen Clearance and Long-Term Clinical Outcomes
小小 胡
Advances in Clinical Medicine (2023) Vol. 13, Iss. 03, pp. 4123-4128
Closed Access
Genetic risk assessment based on association andprediction studies
Nicole Cathlene Astrologo, Joverlyn Gaudillo, Jason R. Albia, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top